HJ Research delivers in-depth insights on the global Canine Arthritis Treatment market in its upcoming report titled, Global Canine Arthritis Treatment Market Report 2018-2029. According to this study, the global Canine Arthritis Treatment market is estimated to be valued at XX Million US$ in 2023 and is projected to reach XX Million US$ by 2029, expanding at a CAGR of XX% during the forecast period. The report on Canine Arthritis Treatment market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, industrial chain, etc.
This report studies the Canine Arthritis Treatment market status and outlook of global and major regions, from angles of players, countries, product types and end industries, this report analyzes the top players in global Canine Arthritis Treatment industry, and splits by product type and applications/end industries. This report also includes the impact of COVID-19 on the Canine Arthritis Treatment industry.
Global Canine Arthritis Treatment market: competitive landscape analysis
This report contains the major manufacturers analysis of the global Canine Arthritis Treatment industry. By understanding the operations of these manufacturers (revenue and gross margin from 2018 to 2023), the reader can understand the strategies and collaborations that the manufacturers are focusing on combat competition in the market.
Global Canine Arthritis Treatment market: types and end industries analysis
The research report includes specific segments such as end industries and product types of Canine Arthritis Treatment. The report provides market size for each type and end industry from 2018 to 2023. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Global Canine Arthritis Treatment market: regional analysis
Geographically, this report is segmented into several key countries, with market size, growth rate of Canine Arthritis Treatment in these countries from 2018 to 2023, which covering United States, Canada, Germany, France, UK, Italy, Russia, Spain, Netherlands, China, Japan, Korea, India, Australia, Indonesia, Vietnam, Turkey, Saudi Arabia, South Africa, Egypt, Brazil, Mexico, Argentina, Colombia.
Key players in global Canine Arthritis Treatment market include:
Elanco (Eli Lilly and Company)
Boehringer Ingelheim
Zoetis Inc
Vetoquinol S.A.
Bayer AG
Aratana Therapeutics Inc
Norbrook Laboratories Limited
VetStem Biopharma
Dechra Pharmaceuticals Plc
Market segmentation, by product types:
Non-Steroidal Anti-Inflammatory Drugs
Opioids
Stem Cell Therapy
Market segmentation, by applications:
Veterinary Hospitals and Clinics
Retail Pharmacies
Drug Stores
E-commerce
1 Industry Overview of Canine Arthritis Treatment
1.1 Research Scope
1.2 Market Segmentation by Types of Canine Arthritis Treatment
1.3 Market Segmentation by End Users of Canine Arthritis Treatment
1.4 Market Dynamics Analysis of Canine Arthritis Treatment
1.4.1 Market Drivers
1.4.2 Market Challenges
1.4.3 Market Opportunities
1.4.4 Porter’s Five Forces
2 Major Manufacturers Analysis of Canine Arthritis Treatment Industry
2.1 Elanco (Eli Lilly and Company)
2.1.1 Company Overview
2.1.2 Main Products and Specifications
2.1.3 Canine Arthritis Treatment Revenue and Gross Margin (2018-2023)
2.1.4 Contact Information
2.2 Boehringer Ingelheim
2.2.1 Company Overview
2.2.2 Main Products and Specifications
2.2.3 Canine Arthritis Treatment Revenue and Gross Margin (2018-2023)
2.2.4 Contact Information
2.3 Zoetis Inc
2.3.1 Company Overview
2.3.2 Main Products and Specifications
2.3.3 Canine Arthritis Treatment Revenue and Gross Margin (2018-2023)
2.3.4 Contact Information
2.4 Vetoquinol S.A.
2.4.1 Company Overview
2.4.2 Main Products and Specifications
2.4.3 Canine Arthritis Treatment Revenue and Gross Margin (2018-2023)
2.4.4 Contact Information
2.5 Bayer AG
2.5.1 Company Overview
2.5.2 Main Products and Specifications
2.5.3 Canine Arthritis Treatment Revenue and Gross Margin (2018-2023)
2.5.4 Contact Information
2.6 Aratana Therapeutics Inc
2.6.1 Company Overview
2.6.2 Main Products and Specifications
2.6.3 Canine Arthritis Treatment Revenue and Gross Margin (2018-2023)
2.6.4 Contact Information
2.7 Norbrook Laboratories Limited
2.7.1 Company Overview
2.7.2 Main Products and Specifications
2.7.3 Canine Arthritis Treatment Revenue and Gross Margin (2018-2023)
2.7.4 Contact Information
2.8 VetStem Biopharma
2.8.1 Company Overview
2.8.2 Main Products and Specifications
2.8.3 Canine Arthritis Treatment Revenue and Gross Margin (2018-2023)
2.8.4 Contact Information
2.9 Dechra Pharmaceuticals Plc
2.9.1 Company Overview
2.9.2 Main Products and Specifications
2.9.3 Canine Arthritis Treatment Revenue and Gross Margin (2018-2023)
2.9.4 Contact Information
3 Global Canine Arthritis Treatment Market Analysis by Regions, Manufacturers, Types and End Users
3.1 Global Sales Revenue of Canine Arthritis Treatment by Regions (2018-2023)
3.2 Global Sales Revenue of Canine Arthritis Treatment by Manufacturers (2018-2023)
3.3 Global Sales Revenue of Canine Arthritis Treatment by Types (2018-2023)
3.4 Global Sales Revenue of Canine Arthritis Treatment by End Users (2018-2023)
4 Northern America Canine Arthritis Treatment Market Analysis by Countries, Types and End Users
4.1 Northern America Canine Arthritis Treatment Sales Revenue Analysis by Countries (2018-2023)
4.2 Northern America Canine Arthritis Treatment Sales Revenue Analysis by Types (2018-2023)
4.3 Northern America Canine Arthritis Treatment Sales Revenue Analysis by End Users (2018-2023)
4.4 United States Canine Arthritis Treatment Sales Revenue Analysis (2018-2023)
4.5 Canada Canine Arthritis Treatment Sales Revenue Analysis (2018-2023)
5 Europe Canine Arthritis Treatment Market Analysis by Countries, Types and End Users
5.1 Europe Canine Arthritis Treatment Sales Revenue Analysis by Countries (2018-2023)
5.2 Europe Canine Arthritis Treatment Sales Revenue Analysis by Types (2018-2023)
5.3 Europe Canine Arthritis Treatment Sales Revenue Analysis by End Users (2018-2023)
5.4 Germany Canine Arthritis Treatment Sales Revenue Analysis (2018-2023)
5.5 France Canine Arthritis Treatment Sales Revenue Analysis (2018-2023)
5.6 UK Canine Arthritis Treatment Sales Revenue Analysis (2018-2023)
5.7 Italy Canine Arthritis Treatment Sales Revenue Analysis (2018-2023)
5.8 Russia Canine Arthritis Treatment Sales Revenue Analysis (2018-2023)
5.9 Spain Canine Arthritis Treatment Sales Revenue Analysis (2018-2023)
5.10 Netherlands Canine Arthritis Treatment Sales Revenue Analysis (2018-2023)
6 Asia Pacific Canine Arthritis Treatment Market Analysis by Countries, Types and End Users
6.1 Asia Pacific Canine Arthritis Treatment Sales Revenue Analysis by Countries (2018-2023)
6.2 Asia Pacific Canine Arthritis Treatment Sales Revenue Analysis by Types (2018-2023)
6.3 Asia Pacific Canine Arthritis Treatment Sales Revenue Analysis by End Users (2018-2023)
6.4 China Canine Arthritis Treatment Sales Revenue Analysis (2018-2023)
6.5 Japan Canine Arthritis Treatment Sales Revenue Analysis (2018-2023)
6.6 Korea Canine Arthritis Treatment Sales Revenue Analysis (2018-2023)
6.7 India Canine Arthritis Treatment Sales Revenue Analysis (2018-2023)
6.8 Australia Canine Arthritis Treatment Sales Revenue Analysis (2018-2023)
6.9 Indonesia Canine Arthritis Treatment Sales Revenue Analysis (2018-2023)
6.10 Vietnam Canine Arthritis Treatment Sales Revenue Analysis (2018-2023)
7 Latin America Canine Arthritis Treatment Market Analysis by Countries, Types and End Users
7.1 Latin America Canine Arthritis Treatment Sales Revenue Analysis by Countries (2018-2023)
7.2 Latin America Canine Arthritis Treatment Sales Revenue Analysis by Types (2018-2023)
7.3 Latin America Canine Arthritis Treatment Sales Revenue Analysis by End Users (2018-2023)
7.4 Brazil Canine Arthritis Treatment Sales Revenue Analysis (2018-2023)
7.5 Mexico Canine Arthritis Treatment Sales Revenue Analysis (2018-2023)
7.6 Argentina Canine Arthritis Treatment Sales Revenue Analysis (2018-2023)
7.7 Colombia Canine Arthritis Treatment Sales Revenue Analysis (2018-2023)
8 Middle East & Africa Canine Arthritis Treatment Market Analysis by Countries, Types and End Users
8.1 Middle East & Africa Canine Arthritis Treatment Sales Revenue Analysis by Countries (2018-2023)
8.2 Middle East & Africa Canine Arthritis Treatment Sales Revenue Analysis by Types (2018-2023)
8.3 Middle East & Africa Canine Arthritis Treatment Sales Revenue Analysis by End Users (2018-2023)
8.4 Turkey Canine Arthritis Treatment Sales Revenue Analysis (2018-2023)
8.5 Saudi Arabia Canine Arthritis Treatment Sales Revenue Analysis (2018-2023)
8.6 South Africa Canine Arthritis Treatment Sales Revenue Analysis (2018-2023)
8.7 Egypt Canine Arthritis Treatment Sales Revenue Analysis (2018-2023)
9 Marketing Channel, Distributors and Traders Analysis
9.1 Marketing Channel
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Distributors and Traders
10 Global Canine Arthritis Treatment Market Forecast by Regions, Countries, Manufacturers, Types and End Users
10.1 Global Sales Revenue Forecast of Canine Arthritis Treatment by Regions (2024-2029)
10.2 Global Sales Revenue Forecast of Canine Arthritis Treatment by Types (2024-2029)
10.3 Global Sales Revenue Forecast of Canine Arthritis Treatment by End Users (2024-2029)
10.4 Global Revenue Forecast of Canine Arthritis Treatment by Countries (2024-2029)
10.4.1 United States Revenue Forecast (2024-2029)
10.4.2 Canada Revenue Forecast (2024-2029)
10.4.3 Germany Revenue Forecast (2024-2029)
10.4.4 France Revenue Forecast (2024-2029)
10.4.5 UK Revenue Forecast (2024-2029)
10.4.6 Italy Revenue Forecast (2024-2029)
10.4.7 Russia Revenue Forecast (2024-2029)
10.4.8 Spain Revenue Forecast (2024-2029)
10.4.9 Netherlands Revenue Forecast (2024-2029)
10.4.10 China Revenue Forecast (2024-2029)
10.4.11 Japan Revenue Forecast (2024-2029)
10.4.12 Korea Revenue Forecast (2024-2029)
10.4.13 India Revenue Forecast (2024-2029)
10.4.14 Australia Revenue Forecast (2024-2029)
10.4.15 Indonesia Revenue Forecast (2024-2029)
10.4.16 Vietnam Revenue Forecast (2024-2029)
10.4.17 Brazil Revenue Forecast (2024-2029)
10.4.18 Mexico Revenue Forecast (2024-2029)
10.4.19 Argentina Revenue Forecast (2024-2029)
10.4.20 Colombia Revenue Forecast (2024-2029)
10.4.21 Turkey Revenue Forecast (2024-2029)
10.4.22 Saudi Arabia Revenue Forecast (2024-2029)
10.4.23 South Africa Revenue Forecast (2024-2029)
10.4.24 Egypt Revenue Forecast (2024-2029)
11 Industry Chain Analysis of Canine Arthritis Treatment
11.1 Upstream Analysis of Canine Arthritis Treatment
11.2 Downstream Major Consumers Analysis of Canine Arthritis Treatment
11.3 Major Suppliers of Canine Arthritis Treatment with Contact Information
11.4 Supply Chain Relationship Analysis of Canine Arthritis Treatment
12 Canine Arthritis Treatment New Project Investment Feasibility Analysis
12.1 Canine Arthritis Treatment New Project SWOT Analysis
12.2 Canine Arthritis Treatment New Project Investment Feasibility Analysis
12.2.1 Project Name
12.2.2 Investment Budget
12.2.3 Project Product Solutions
12.2.4 Project Schedule
13 Canine Arthritis Treatment Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.2 References and Data Sources
14.2.1 Primary Sources
14.2.2 Secondary Paid Sources
14.2.3 Secondary Public Sources
14.3 Abbreviations and Units of Measurement
14.4 Author Details
14.5 Disclaimer
Table Types of Canine Arthritis Treatment
Table End Users of Canine Arthritis Treatment
Figure Market Drivers Analysis of Canine Arthritis Treatment
Figure Market Challenges Analysis of Canine Arthritis Treatment
Figure Market Opportunities Analysis of Canine Arthritis Treatment
Table Market Drivers Analysis of Canine Arthritis Treatment
Table Elanco (Eli Lilly and Company) Information List
Figure Canine Arthritis Treatment Specifications of Elanco (Eli Lilly and Company)
Table Canine Arthritis Treatment Revenue (Million USD) and Gross Margin of Elanco (Eli Lilly and Company) (2018-2023)
Figure Canine Arthritis Treatment Revenue (Million USD) and Global Market Share of Elanco (Eli Lilly and Company) (2018-2023)
Table Boehringer Ingelheim Information List
Figure Canine Arthritis Treatment Specifications of Boehringer Ingelheim
Table Canine Arthritis Treatment Revenue (Million USD) and Gross Margin of Boehringer Ingelheim (2018-2023)
Figure Canine Arthritis Treatment Revenue (Million USD) and Global Market Share of Boehringer Ingelheim (2018-2023)
Table Zoetis Inc Information List
Figure Canine Arthritis Treatment Specifications of Zoetis Inc
Table Canine Arthritis Treatment Revenue (Million USD) and Gross Margin of Zoetis Inc (2018-2023)
Figure Canine Arthritis Treatment Revenue (Million USD) and Global Market Share of Zoetis Inc (2018-2023)
Table Vetoquinol S.A. Information List
Figure Canine Arthritis Treatment Specifications of Vetoquinol S.A.
Table Canine Arthritis Treatment Revenue (Million USD) and Gross Margin of Vetoquinol S.A. (2018-2023)
Figure Canine Arthritis Treatment Revenue (Million USD) and Global Market Share of Vetoquinol S.A. (2018-2023)
Table Bayer AG Information List
Figure Canine Arthritis Treatment Specifications of Bayer AG
Table Canine Arthritis Treatment Revenue (Million USD) and Gross Margin of Bayer AG (2018-2023)
Figure Canine Arthritis Treatment Revenue (Million USD) and Global Market Share of Bayer AG (2018-2023)
Table Aratana Therapeutics Inc Information List
Figure Canine Arthritis Treatment Specifications of Aratana Therapeutics Inc
Table Canine Arthritis Treatment Revenue (Million USD) and Gross Margin of Aratana Therapeutics Inc (2018-2023)
Figure Canine Arthritis Treatment Revenue (Million USD) and Global Market Share of Aratana Therapeutics Inc (2018-2023)
Table Norbrook Laboratories Limited Information List
Figure Canine Arthritis Treatment Specifications of Norbrook Laboratories Limited
Table Canine Arthritis Treatment Revenue (Million USD) and Gross Margin of Norbrook Laboratories Limited (2018-2023)
Figure Canine Arthritis Treatment Revenue (Million USD) and Global Market Share of Norbrook Laboratories Limited (2018-2023)
Table VetStem Biopharma Information List
Figure Canine Arthritis Treatment Specifications of VetStem Biopharma
Table Canine Arthritis Treatment Revenue (Million USD) and Gross Margin of VetStem Biopharma (2018-2023)
Figure Canine Arthritis Treatment Revenue (Million USD) and Global Market Share of VetStem Biopharma (2018-2023)
Table Dechra Pharmaceuticals Plc Information List
Figure Canine Arthritis Treatment Specifications of Dechra Pharmaceuticals Plc
Table Canine Arthritis Treatment Revenue (Million USD) and Gross Margin of Dechra Pharmaceuticals Plc (2018-2023)
Figure Canine Arthritis Treatment Revenue (Million USD) and Global Market Share of Dechra Pharmaceuticals Plc (2018-2023)
Table Global Revenue (Million USD) of Canine Arthritis Treatment by Regions (2018-2023)
Table Global Revenue (Million USD) of Canine Arthritis Treatment by Manufacturers (2018-2023)
Table Global Revenue (Million USD) of Canine Arthritis Treatment by Types (2018-2023)
Table Global Revenue (Million USD) of Canine Arthritis Treatment by End Users (2018-2023)
Table Northern America Canine Arthritis Treatment Revenue (Million USD) by Countries (2018-2023)
Table Northern America Canine Arthritis Treatment Revenue (Million USD) by Types (2018-2023)
Table Northern America Canine Arthritis Treatment Revenue (Million USD) by End Users (2018-2023)
Figure United States Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Canada Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Table Europe Canine Arthritis Treatment Revenue (Million USD) by Countries (2018-2023)
Table Europe Canine Arthritis Treatment Revenue (Million USD) by Types (2018-2023)
Table Europe Canine Arthritis Treatment Revenue (Million USD) by End Users (2018-2023)
Figure Germany Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure France Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure UK Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Italy Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Russia Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Spain Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Netherlands Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Table Asia Pacific Canine Arthritis Treatment Revenue (Million USD) by Countries (2018-2023)
Table Asia Pacific Canine Arthritis Treatment Revenue (Million USD) by Types (2018-2023)
Table Asia Pacific Canine Arthritis Treatment Revenue (Million USD) by End Users (2018-2023)
Figure China Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Japan Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Korea Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure India Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Australia Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Indonesia Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Vietnam Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Table Latin America Canine Arthritis Treatment Revenue (Million USD) by Countries (2018-2023)
Table Latin America Canine Arthritis Treatment Revenue (Million USD) by Types (2018-2023)
Table Latin America Canine Arthritis Treatment Revenue (Million USD) by End Users (2018-2023)
Figure Brazil Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Mexico Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Argentina Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Colombia Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Table Middle East & Africa Canine Arthritis Treatment Revenue (Million USD) by Countries (2018-2023)
Table Middle East & Africa Canine Arthritis Treatment Revenue (Million USD) by Types (2018-2023)
Table Middle East & Africa Canine Arthritis Treatment Revenue (Million USD) by End Users (2018-2023)
Figure Turkey Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Saudi Arabia Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure South Africa Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Egypt Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Table Global Revenue (Million USD) Forecast of Canine Arthritis Treatment by Regions (2024-2029)
Table Global Revenue (Million USD) Forecast of Canine Arthritis Treatment by Types (2024-2029)
Table Global Revenue (Million USD) Forecast of Canine Arthritis Treatment by End Users (2024-2029)
Table Major Consumers with Contact Information of Canine Arthritis Treatment
Table Major Suppliers of Canine Arthritis Treatment with Contact Information
Figure Supply Chain Relationship Analysis of Canine Arthritis Treatment
Table New Project SWOT Analysis of Canine Arthritis Treatment
Table Project Appraisal and Financing
Table New Project Construction Period
Table New Project Investment Feasibility Analysis of Canine Arthritis Treatment
Table Research Programs/Design for This Report
Table Key Data Information from Primary Sources
Table Key Data Information from Secondary Sources
Table Part of Interviewees Record List of Canine Arthritis Treatment Industry
Table Part of References List of Canine Arthritis Treatment Industry
Table Units of Measurement List
Table Part of Author Details List of Canine Arthritis Treatment Industry
HJ Research employs comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecast possible. At HJ Research, our researchers and domain experts use a unique blend of primary and secondary research, with validation and iterations at every stage, in order to minimize deviation and present the most accurate analysis of the Canine Arthritis Treatment industry. Critical elements of methodology employed for all our studies include:
Secondary Sources:
The research team first works with national bureau of statistics, national customs, market research association, state information center, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Secondary sources are mainly from press releases, company reports and publications, non-profit organizations, industry associations, government publications, economic and demographic data and customs data. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Primary Research:
In the primary research process, for comprehensive understanding of the Canine Arthritis Treatment market, it is essential to understand the complete value chain and in order to facilitate this, we collect data from Canine Arthritis Treatment manufacturers, Canine Arthritis Treatment raw material suppliers, Canine Arthritis Treatment distributors as well as buyers. The primary sources from the supply side include Canine Arthritis Treatment manufacturers, opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the Canine Arthritis Treatment raw materials suppliers and producers, etc. The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users, and related key executives from various key companies and organizations operating in the global market.
Technical issues and trends are obtained from surveys, technical symposia and trade journals. Technical data is also gathered from intellectual property perspective, focusing on white space and freedom of movement. Industry dynamics with respect to drivers, restraints, pricing trends are also gathered.
Statistical Model and Data Analysis:
Our market estimates and forecasts are derived through simulation models. A unique model is created customized for each study. Gathered information for market dynamics, technology landscape, application development and pricing trends is fed into the model and analyzed simultaneously. These factors are studied on a comparative basis, and their impact over the forecast period is quantified with the help of correlation, regression and time series analysis. Market forecasting is performed via a combination of economic tools, technological analysis, and industry experience and domain expertise. Qualitative analysis includes: Canine Arthritis Treatment industry landscape and trends, Canine Arthritis Treatment market dynamics and key issues, Canine Arthritis Treatment technology landscape, market opportunities, porter’s analysis and PESTEL analysis, Canine Arthritis Treatment competitive landscape and component benchmarking, policy and regulatory scenario. Quantitative analysis includes: Canine Arthritis Treatment market size and forecast by regions, Canine Arthritis Treatment market size and forecast by application, Canine Arthritis Treatment market size and forecast by types, Canine Arthritis Treatment company market share etc.
Quality Control:
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the HJ Research’s internal quality process.
